Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 232

1.

Human blood Tfr cells are indicators of ongoing humoral activity not fully licensed with suppressive function.

Fonseca VR, Agua-Doce A, Maceiras AR, Pierson W, Ribeiro F, Romão VC, Pires AR, da Silva SL, Fonseca JE, Sousa AE, Linterman MA, Graca L.

Sci Immunol. 2017 Aug 11;2(14). pii: eaan1487. doi: 10.1126/sciimmunol.aan1487.

PMID:
28802258
2.

Uniformity of Peptide Release Is Maintained by Methylation of Release Factors.

Pierson WE, Hoffer ED, Keedy HE, Simms CL, Dunham CM, Zaher HS.

Cell Rep. 2016 Sep 27;17(1):11-18. doi: 10.1016/j.celrep.2016.08.085.

3.

A novel Zap70 mutation with reduced protein stability demonstrates the rate-limiting threshold for Zap70 in T-cell receptor signalling.

Cauwe B, Tian L, Franckaert D, Pierson W, Staats KA, Schlenner SM, Liston A.

Immunology. 2014 Mar;141(3):377-87. doi: 10.1111/imm.12199.

4.

Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3⁺ regulatory T cells.

Pierson W, Cauwe B, Policheni A, Schlenner SM, Franckaert D, Berges J, Humblet-Baron S, Schönefeldt S, Herold MJ, Hildeman D, Strasser A, Bouillet P, Lu LF, Matthys P, Freitas AA, Luther RJ, Weaver CT, Dooley J, Gray DH, Liston A.

Nat Immunol. 2013 Sep;14(9):959-65. doi: 10.1038/ni.2649. Epub 2013 Jul 14.

5.

The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-α receptor.

Papadopoulou AS, Dooley J, Linterman MA, Pierson W, Ucar O, Kyewski B, Zuklys S, Hollander GA, Matthys P, Gray DH, De Strooper B, Liston A.

Nat Immunol. 2011 Dec 18;13(2):181-7. doi: 10.1038/ni.2193.

6.

Foxp3+ follicular regulatory T cells control the germinal center response.

Linterman MA, Pierson W, Lee SK, Kallies A, Kawamoto S, Rayner TF, Srivastava M, Divekar DP, Beaton L, Hogan JJ, Fagarasan S, Liston A, Smith KG, Vinuesa CG.

Nat Med. 2011 Jul 24;17(8):975-82. doi: 10.1038/nm.2425.

7.

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial.

Applegate RJ, Hermiller JJ, Sanz M, Doostzadeh J, Pierson W, Su X, Lansky AJ, Sudhir K, Stone GW.

EuroIntervention. 2010 Sep;6(4):437-46. doi: 10.4244/EIJ30V6I4A75.

8.

A new role for interleukin-10 in immune regulation.

Pierson W, Liston A.

Immunol Cell Biol. 2010 Nov-Dec;88(8):769-70. doi: 10.1038/icb.2010.105. Epub 2010 Aug 17. No abstract available.

PMID:
20714338
9.

An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: a pooled analysis from the SPIRIT II and SPIRIT III trials.

Bartorelli AL, Serruys PW, Miquel-Hébert K, Yu S, Pierson W, Stone GW; SPIRIT II SPIRIT III Investigators.

Catheter Cardiovasc Interv. 2010 Jul 1;76(1):60-6. doi: 10.1002/ccd.22452.

PMID:
20578194
10.

Pharmacokinetic sub-study in the SPIRIT III Randomized and Controlled Trial of XIENCE V everolimus eluting coronary stent system.

Wang Q, Pierson W, Sood P, Bol C, Cannon L, Gordon P, Saucedo J, Sudhir K.

J Interv Cardiol. 2010 Feb;23(1):26-32. doi: 10.1111/j.1540-8183.2009.00517.x. Epub 2009 Dec 17.

PMID:
20040005
11.

Preprocedural inflammation does not affect neointimal hyperplasia following everolimus-eluting stent implantation.

Nakatani D, Ako J, Yamasaki M, Shimohama T, Hasegawa T, Otake H, Waseda K, Tsujino I, Sakurai R, Koo BK, Chang H, Yock PG, Sudhir K, Pierson W, Stone GW, Saito S, Honda Y, Fitzgerald PJ.

J Invasive Cardiol. 2009 Dec;21(12):613-7.

12.

Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: a post hoc analysis of the SPIRIT III randomized trial.

Hermiller JB, Fergus T, Pierson W, Su X, Sood P, Sudhir K, Stone GW.

Am Heart J. 2009 Dec;158(6):1005-10. doi: 10.1016/j.ahj.2009.09.018.

PMID:
19958868
13.

Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.

Doostzadeh J, Clark LN, Bezenek S, Pierson W, Sood PR, Sudhir K.

Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550. Review.

PMID:
19952925
14.

Real-world particulate matter and gaseous emissions from motor vehicles in a highway tunnel.

Gertler AW, Gillies JA, Pierson WR, Rogers CF, Sagebiel JC, Abu-Allaban M, Coulombe W, Tarnay L, Cahill TA.

Res Rep Health Eff Inst. 2002 Jan;(107):5-56; discussion 79-92.

PMID:
11954677
15.

Time-resolved characterization of diesel particulate emissions. 2. Instruments for elemental and organic carbon measurements.

Moosmüller H, Arnott WP, Rogers CF, Bowen JL, Gillies JA, Pierson WR, Collins JF, Durbin TD, Norbeck JM.

Environ Sci Technol. 2001 May 15;35(10):1935-42.

PMID:
11393971
16.

Time resolved characterization of diesel particulate emissions. 1. Instruments for particle mass measurements.

Moosmüller H, Arnott WP, Rogers CF, Bowen JL, Gillies JA, Pierson WR, Collins JF, Durbin TD, Norbeck JM.

Environ Sci Technol. 2001 Feb 15;35(4):781-7.

PMID:
11349292
17.

Management of elder abuse in the emergency department.

Clarke ME, Pierson W.

Emerg Med Clin North Am. 1999 Aug;17(3):631-44, vi. Review.

PMID:
10516843
18.

Considering the nature of intersubjectivity within professional nursing.

Pierson W.

J Adv Nurs. 1999 Aug;30(2):294-302. Review.

PMID:
10457230
19.

Assessment of Nontailpipe Hydrocarbon Emissions from Motor Vehicles.

Pierson WR, Schorran DE, Fujita EM, Sagebiel JC, Lawson DR, Tanner RL.

J Air Waste Manag Assoc. 1999 May;49(5):498-519. doi: 10.1080/10473289.1999.10463827.

PMID:
28072305
20.

Reflection and nursing education.

Pierson W.

J Adv Nurs. 1998 Jan;27(1):165-70. Review.

PMID:
9515621
21.

Financial implications of noninvasive positive pressure ventilation (NPPV).

Criner GJ, Kreimer DT, Tomaselli M, Pierson W, Evans D.

Chest. 1995 Aug;108(2):475-81.

PMID:
7634887
22.
23.

The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma.

Israel E, Rubin P, Kemp JP, Grossman J, Pierson W, Siegel SC, Tinkelman D, Murray JJ, Busse W, Segal AT, Fish J, Kaiser HB, Ledford D, Wenzel S, Rosenthal R, Cohn J, Lanni C, Pearlman H, Karahalios P, Drazen JM.

Ann Intern Med. 1993 Dec 1;119(11):1059-66.

PMID:
8239223
24.

Pulmonary function changes in children associated with fine particulate matter.

Koenig JQ, Larson TV, Hanley QS, Rebolledo V, Dumler K, Checkoway H, Wang SZ, Lin D, Pierson WE.

Environ Res. 1993 Oct;63(1):26-38.

PMID:
8404772
25.

Respiratory effects of inhaled sulfuric acid on senior asthmatics and nonasthmatics.

Koenig JQ, Dumler K, Rebolledo V, Williams PV, Pierson WE.

Arch Environ Health. 1993 May-Jun;48(3):171-5.

PMID:
8333787
26.

Particulate air pollution and hospital emergency room visits for asthma in Seattle.

Schwartz J, Slater D, Larson TV, Pierson WE, Koenig JQ.

Am Rev Respir Dis. 1993 Apr;147(4):826-31.

PMID:
8466116
27.

Respiratory effects of air pollution on allergic disease.

Pierson WE, Koenig JQ.

J Allergy Clin Immunol. 1992 Oct;90(4 Pt 1):557-66. Review.

PMID:
1401639
28.
29.

System interactions of air pollutants.

Pierson WE.

Otolaryngol Head Neck Surg. 1992 Jun;106(6):733-5.

PMID:
1608641
30.

Theophylline mitigates the bronchoconstrictor effects of sulfur dioxide in subjects with asthma.

Koenig JQ, Dumler K, Rebolledo V, Williams PV, Pierson WE.

J Allergy Clin Immunol. 1992 Apr;89(4):789-94.

PMID:
1560163
31.

Response of young asthmatic patients to inhaled sulfuric acid.

Hanley QS, Koenig JQ, Larson TV, Anderson TL, van Belle G, Rebolledo V, Covert DS, Pierson WE.

Am Rev Respir Dis. 1992 Feb;145(2 Pt 1):326-31.

PMID:
1736736
32.

Cromolyn versus triamcinolone acetonide for youngsters with moderate asthma.

Shapiro GG, Sharpe M, DeRouen TA, Pierson WE, Furukawa CT, Virant FS, Bierman CW.

J Allergy Clin Immunol. 1991 Nov;88(5):742-8.

PMID:
1955633
33.

Acute pulmonary effects of nitrogen dioxide exposure during exercise in competitive athletes.

Kim SU, Koenig JQ, Pierson WE, Hanley QS.

Chest. 1991 Apr;99(4):815-9.

PMID:
2009780
34.

Immunologic defects in patients with refractory sinusitis.

Shapiro GG, Virant FS, Furukawa CT, Pierson WE, Bierman CW.

Pediatrics. 1991 Mar;87(3):311-6.

PMID:
2000270
35.

Air pollutants and the respiratory system: toxicity and pharmacologic interventions.

Koenig JQ, Pierson WE.

J Toxicol Clin Toxicol. 1991;29(3):401-11. Review.

PMID:
1920573
36.
37.

Effects of albuterol and procaterol on exercise-induced asthma.

Shapiro GG, Kemp JP, DeJong R, Chapko M, Bierman CW, Altman LC, Furukawa CT, Meltzer E, Orgel A, Pierson WE, et al.

Ann Allergy. 1990 Oct;65(4):273-6.

PMID:
2145791
38.

The use of smokeless tobacco among basic airmen.

Daly MB, Pierson W.

Am J Health Promot. 1990 Mar;4(4):266-9. doi: 10.4278/0890-1171-4.4.266.

PMID:
22204509
39.

Long-term, double-blind comparison of controlled-release albuterol versus sustained-release theophylline in adolescents and adults with asthma.

Pierson WE, LaForce CF, Bell TD, MacCosbe PE, Sykes RS, Tinkelman D.

J Allergy Clin Immunol. 1990 Mar;85(3):618-26.

PMID:
2179367
40.

Prior exposure to ozone potentiates subsequent response to sulfur dioxide in adolescent asthmatic subjects.

Koenig JQ, Covert DS, Hanley QS, van Belle G, Pierson WE.

Am Rev Respir Dis. 1990 Feb;141(2):377-80.

PMID:
2301855
41.

Antihistamines in asthma.

Pierson WE, Virant FS.

Ann Allergy. 1989 Dec;63(6 Pt 2):601-3. Review. No abstract available.

PMID:
2574551
42.

Terfenadine blockade of exercise-induced bronchospasm.

Pierson WE, Furukawa CT, Shapiro GG, Altman LC, Bierman CW.

Ann Allergy. 1989 Nov;63(5):461-4.

PMID:
2573300
43.

Potential adverse health effects of wood smoke.

Pierson WE, Koenig JQ, Bardana EJ Jr.

West J Med. 1989 Sep;151(3):339-42. Review.

44.

Beta-adrenergic blockers, immunotherapy, and skin testing. American Academy of Allergy and Immunology.

Kaplan AP, Anderson JA, Valentine MD, Lockey RF, Pierson WE, Zweiman B, Kaliner MA, Lichtenstein LM, Lieberman PL, Settipane GA, et al.

J Allergy Clin Immunol. 1989 Jul;84(1):129-30. No abstract available.

PMID:
2569002
45.

Impact of air pollutants on athletic performance.

Pierson WE.

Allergy Proc. 1989 May-Jun;10(3):209-14. Review.

PMID:
2670670
46.

Alterations in oxygen saturation and ventilation after intravenous sedation for peritoneoscopy.

Brady CE 3rd, Harkleroad LE, Pierson WP.

Arch Intern Med. 1989 May;149(5):1029-32.

PMID:
2524181
47.

Pulmonary effects of sulfur dioxide exposure and ipratropium bromide pretreatment in adults with nonallergic asthma.

McManus MS, Koenig JQ, Altman LC, Pierson WE.

J Allergy Clin Immunol. 1989 Mar;83(3):619-26.

PMID:
2522475
48.

Dr. Justina Ford. Honored as first black female physician in Colorado. Home and office dedicated as medical and minority memorial.

Pierson WS.

Colo Med. 1989 Feb 15;86(4):60. No abstract available. Erratum in: Colo Med 1989 Mar 1;86(5):84.

PMID:
2645080
49.

Studies of neutrophil chemotactic factor of anaphylaxis in metabisulfite sensitivity.

Sprenger JD, Altman LC, Marshall SG, Pierson WE, Koenig JQ.

Ann Allergy. 1989 Feb;62(2):117-21.

PMID:
2919798
50.

Effects of inhalation of acidic compounds on pulmonary function in allergic adolescent subjects.

Koenig JQ, Covert DS, Pierson WE.

Environ Health Perspect. 1989 Feb;79:173-8.

Supplemental Content

Loading ...
Support Center